TW200414900A - - Google Patents
Download PDFInfo
- Publication number
- TW200414900A TW200414900A TW92117738A TW92117738A TW200414900A TW 200414900 A TW200414900 A TW 200414900A TW 92117738 A TW92117738 A TW 92117738A TW 92117738 A TW92117738 A TW 92117738A TW 200414900 A TW200414900 A TW 200414900A
- Authority
- TW
- Taiwan
- Prior art keywords
- weight
- coating suspension
- coating
- film
- forming agent
- Prior art date
Links
- 238000000576 coating method Methods 0.000 claims description 302
- 239000011248 coating agent Substances 0.000 claims description 289
- 239000000725 suspension Substances 0.000 claims description 214
- 239000003795 chemical substances by application Substances 0.000 claims description 116
- 229920000642 polymer Polymers 0.000 claims description 106
- 230000000149 penetrating effect Effects 0.000 claims description 98
- 239000002552 dosage form Substances 0.000 claims description 77
- 238000000034 method Methods 0.000 claims description 64
- 230000003204 osmotic effect Effects 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 238000013270 controlled release Methods 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 27
- 239000002775 capsule Substances 0.000 claims description 26
- 239000007787 solid Substances 0.000 claims description 26
- 238000009472 formulation Methods 0.000 claims description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- 239000013543 active substance Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 20
- 239000010408 film Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 12
- 230000004888 barrier function Effects 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 239000011877 solvent mixture Substances 0.000 claims description 11
- 239000002357 osmotic agent Substances 0.000 claims description 10
- 239000003960 organic solvent Substances 0.000 claims description 9
- 230000035515 penetration Effects 0.000 claims description 6
- 239000003125 aqueous solvent Substances 0.000 claims description 5
- 230000002079 cooperative effect Effects 0.000 claims description 5
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 239000012466 permeate Substances 0.000 claims description 3
- 229910052702 rhenium Inorganic materials 0.000 claims description 3
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 238000010422 painting Methods 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000010410 layer Substances 0.000 claims 6
- -1 Natraso Polymers 0.000 claims 3
- 229920000578 graft copolymer Polymers 0.000 claims 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 2
- 229920002554 vinyl polymer Polymers 0.000 claims 2
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 239000004698 Polyethylene Substances 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 239000011247 coating layer Substances 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 1
- 229940098465 tincture Drugs 0.000 claims 1
- 238000005507 spraying Methods 0.000 description 16
- 239000007921 spray Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 239000008199 coating composition Substances 0.000 description 6
- 238000005336 cracking Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000015170 shellfish Nutrition 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960002146 guaifenesin Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100353170 Caenorhabditis elegans pri-2 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920000875 Dissolving pulp Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000008376 breath freshener Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940000033 dermatological agent Drugs 0.000 description 1
- 239000003241 dermatological agent Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003128 rodenticide Substances 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Paper (AREA)
- Paints Or Removers (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39277502P | 2002-06-28 | 2002-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200414900A true TW200414900A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2004-08-16 |
Family
ID=30000934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW92117738A TW200414900A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2002-06-28 | 2003-06-27 |
Country Status (15)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI453167B (zh) * | 2007-08-08 | 2014-09-21 | Gen Electric | 控制含水系統中微生物之生物膜的方法 |
| TWI487673B (zh) * | 2007-08-08 | 2015-06-11 | Gen Electric | 提供細菌生息場所之原生動物的控制方法 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| KR101306635B1 (ko) | 2005-06-27 | 2013-10-11 | 밸리언트 인터내셔널(바베이도스) 에스알엘 | 부프로피온염의 개질-방출 제형 |
| EP2032124A1 (en) * | 2006-06-27 | 2009-03-11 | Biovail Laboratories International Srl | Multiparticulate osmotic delivery system |
| US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
| US20090004281A1 (en) * | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
| US20110052655A1 (en) * | 2007-08-08 | 2011-03-03 | Wilson Kurt Whitekettle | Methods and vesicles for controlling protozoa |
| US8784659B2 (en) * | 2007-08-08 | 2014-07-22 | General Electric Company | Method for controlling microbial biofilm in aqueous systems |
| CN102871982B (zh) | 2012-10-16 | 2014-09-10 | 中国科学院上海药物研究所 | 一种药物渗透泵制剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US36472A (en) * | 1862-09-16 | Cttlvebt | ||
| US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
| US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
| US5800422A (en) * | 1995-06-02 | 1998-09-01 | Alza Corporation | Osmotic device with delayed activation of drug delivery and complete drug release |
| DE69915346T2 (de) * | 1998-12-17 | 2004-07-22 | Alza Corp., Mountain View | Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen |
| US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
-
2003
- 2003-06-27 TW TW92117738A patent/TW200414900A/zh unknown
- 2003-06-27 AR ARP030102341A patent/AR040301A1/es not_active Application Discontinuation
- 2003-06-28 CN CNA038206978A patent/CN1678292A/zh active Pending
- 2003-06-28 NZ NZ537343A patent/NZ537343A/en not_active IP Right Cessation
- 2003-06-28 MX MXPA05000207A patent/MXPA05000207A/es not_active Application Discontinuation
- 2003-06-28 CA CA002490683A patent/CA2490683A1/en not_active Abandoned
- 2003-06-28 KR KR1020047021455A patent/KR20050071375A/ko not_active Withdrawn
- 2003-06-28 JP JP2004518242A patent/JP2005532374A/ja not_active Withdrawn
- 2003-06-28 WO PCT/US2003/021361 patent/WO2004002450A1/en active Application Filing
- 2003-06-28 EP EP03762340A patent/EP1528913A1/en not_active Withdrawn
- 2003-06-28 AU AU2003248868A patent/AU2003248868A1/en not_active Abandoned
- 2003-06-28 US US10/609,061 patent/US7338663B2/en not_active Expired - Lifetime
- 2003-06-28 IL IL16586403A patent/IL165864A0/xx unknown
-
2005
- 2005-01-12 NO NO20050181A patent/NO20050181L/no not_active Application Discontinuation
- 2005-01-27 ZA ZA200500826A patent/ZA200500826B/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI453167B (zh) * | 2007-08-08 | 2014-09-21 | Gen Electric | 控制含水系統中微生物之生物膜的方法 |
| TWI487673B (zh) * | 2007-08-08 | 2015-06-11 | Gen Electric | 提供細菌生息場所之原生動物的控制方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AR040301A1 (es) | 2005-03-23 |
| EP1528913A1 (en) | 2005-05-11 |
| ZA200500826B (en) | 2006-08-30 |
| JP2005532374A (ja) | 2005-10-27 |
| AU2003248868A1 (en) | 2004-01-19 |
| US20040058002A1 (en) | 2004-03-25 |
| WO2004002450A1 (en) | 2004-01-08 |
| NZ537343A (en) | 2007-06-29 |
| IL165864A0 (en) | 2006-01-15 |
| US7338663B2 (en) | 2008-03-04 |
| KR20050071375A (ko) | 2005-07-07 |
| NO20050181L (no) | 2005-01-12 |
| CA2490683A1 (en) | 2004-01-08 |
| MXPA05000207A (es) | 2005-06-06 |
| CN1678292A (zh) | 2005-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109641061A (zh) | 包含纤维素纳米纤维(cnf)以及包括闭孔的多孔固体材料药物载体 | |
| FI84783B (fi) | Foerfarande foer framstaellning av ett farmaceutiskt preparat i enhetsdosform. | |
| JP4825385B2 (ja) | 薬理学的活性物質またはその他の物質の二相放出用薄膜製剤 | |
| NZ545498A (en) | Rapid dissolution formulation of a calcium receptor-active compound | |
| Utomo et al. | Development of 3D-printed vaginal devices containing metronidazole for alternative bacterial vaginosis treatment | |
| PL172571B1 (pl) | Doustny preparat morfiny PL PL PL | |
| DE60211769T2 (de) | Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen | |
| TW200414900A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| AU4035299A (en) | Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates | |
| Farooqui et al. | Formulation development and optimisation of fast dissolving buccal films loaded glimepiride solid dispersion with enhanced dissolution profile using central composite design | |
| JPH06206833A (ja) | 薬剤学的薬剤 | |
| EP1722821B1 (en) | Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same | |
| CN106420662A (zh) | 固体分子分散体 | |
| CN103096880A (zh) | 不愉快味道被掩蔽的含药膜包覆的颗粒 | |
| Kumar et al. | Formulation and evaluation of fast dissolving tablet of montelukast by using co-processed excipients | |
| C Patel et al. | Development of controlled release osmotic pump tablet of glipizide solid dispersion | |
| CN105748421B (zh) | 一种含盐酸曲唑酮的缓释片及其制备方法 | |
| Piao et al. | Comparison of release-controlling efficiency of polymeric coating materials using matrix-type casted films and diffusion-controlled coated tablet | |
| Kumar et al. | Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation—a technical note | |
| Bi et al. | A controlled porosity osmotic pump system with biphasic release of theophylline | |
| Chhater et al. | Solid dispersion incorporated microcapsules: predictive tools for improve the half life and dissolution rate of pioglitazone hydrochloride | |
| WO2004108164A1 (ja) | コーティング用組成物およびコーティング製剤 | |
| NZ251806A (en) | Making compressed tablets containing aminoguanidine or a salt thereof and a binder, by first spray-drying an aqueous solution to form a powder | |
| Lakshmi et al. | Design and Evaluation of Starch Acetate-Glipizide Microparticulate Drug Delivery Systems for Oral Controlled Release: Invitro Studies | |
| RU2228747C1 (ru) | Антиангинальное средство пролонгированного действия |